Yanqin LIU
10Patents
1h-index
16Co-inventors
43Inventor score
Filing activity: Oct 11, 2019 → May 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD972856S1 | Plant stand | General | 13 | Active |
| US11691981B2 | Heterocyclic compounds, preparation methods therefor, and methods of uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12110289B2 | Heterocyclic compounds, preparation methods and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12246020B2 | Heterocyclic compounds, preparation methods and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11241437B2 | Heterocyclic compounds, preparation methods and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12173010B2 | Heterocyclic compounds, preparation methods therefor, and methods of uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12391677B2 | Thyroid hormone receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US12256737B2 | Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agents | Human Necessities | 0 | Active |
| US11865115B2 | Heterocyclic compounds, preparation methods and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12427146B2 | C-terminal SRC kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.